Self Sterilizing Medical Devices Market Global Report 2026

The self sterilizing medical devices market size has grown rapidly in recent years. It will grow from $0.98 billion in 2025 to $1.11 billion in 2026 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to increasing hospital-acquired infection burden, rising demand for surgical hygiene standards, growth in reusable medical instrument usage, expansion of hospital infrastructure in emerging markets, and early adoption of antimicrobial coatings in medical devices.

The self sterilizing medical devices market size is expected to see rapid growth in the next few years. It will grow to $1.88 billion in 2030 at a compound annual growth rate (CAGR) of 14%. The growth in the forecast period can be attributed to increasing integration of self-disinfecting materials in medical devices, rising demand for autonomous infection prevention systems, growth in minimally invasive surgical procedures, expansion of advanced healthcare infrastructure in developing regions, and increasing focus on reducing cross-contamination in clinical workflows. Major trends in the forecast period include rising adoption of UV-C based embedded sterilization in reusable medical devices, growth of antimicrobial coating innovations for infection resistance in clinical instruments, expansion of hospital-acquired infection (HAI) prevention protocols driving integration of self-sterilizing devices, increasing regulatory mandates for validation and certification of autonomous sterilization medical technologies, and advancement in biocompatible self-disinfecting surface materials for long-term clinical usage.

The increasing prevalence of hospital-acquired infections is expected to drive the growth of the self-sterilizing medical devices market going forward. Hospital-acquired infections (HAIs) refer to infections that a patient develops while receiving medical care in a healthcare facility, which were not present or incubating at the time of admission. The rising prevalence of hospital-acquired infections is attributed to poor infection control practices such as inadequate hand hygiene, improper sterilization of medical equipment, and non-compliance with standard safety protocols, which facilitate the spread of pathogens within healthcare settings. Self-sterilizing medical devices help reduce hospital-acquired infections by continuously eliminating microbial contamination on device surfaces, thereby minimizing cross-contamination and improving patient safety in healthcare environments. For instance, in November 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2022-23, hospital-acquired complications (HACs) were recorded in 115,000 public hospitalizations (2%) and 34,200 private hospitalizations (0.8%). The most common complication was healthcare-associated infection (37%), followed by delirium (13%) and cardiac complications (12%). Therefore, the increasing prevalence of hospital-acquired infections is expected to drive the growth of the self-sterilizing medical devices market.

The expansion in surgical procedures is expected to drive the growth of the self-sterilizing medical devices market going forward. Surgical procedures refer to medical interventions that involve operative techniques to treat diseases, injuries, or deformities through manual or instrumental methods. The expansion in surgical procedures is mainly driven by the rising burden of chronic diseases, which increases the need for ongoing medical interventions and corrective surgeries to manage long-term conditions. Self-sterilizing medical devices support surgical procedures by continuously reducing microbial contamination on instruments, surfaces, and medical textiles, thereby lowering the risk of surgical site infections and improving patient outcomes. For instance, in March 2024, according to the 2024 annual report by Intuitive Surgical Inc., a US-based medical device company, approximately 2,683,000 surgical procedures were performed using da Vinci surgical systems, up from around 2,286,000 procedures in 2023 and 1,875,000 procedures in 2022, reflecting steady year-over-year growth in utilization. Therefore, the expansion in surgical procedures is driving the growth of the self-sterilizing medical devices market.

The rising healthcare expenditure is expected to drive the growth of the self-sterilizing medical devices market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to higher overall healthcare spending. Rising healthcare expenditure enables greater investment in advanced infection-control technologies and premium medical innovations, thereby accelerating the adoption of self-sterilizing medical devices across healthcare systems. For instance, in December 2024, according to the Centers for Medicare and Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures grew by 7.5%, reaching $4.9 trillion, or approximately $14,570 per person. Therefore, the rising healthcare expenditure is driving the growth of the self-sterilizing medical devices market.

Major companies operating in the self sterilizing medical devices market are Johnson & Johnson, Becton Dickinson and Company (BD), Stryker Corporation, Teleflex Incorporated, Cook Medical, Mölnlycke Health Care, Noble Biomaterials Inc., CytaCoat AB.

North America was the dominant region in the self sterilizing medical devices market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in self sterilizing medical devices report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the self sterilizing medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The self sterilizing medical devices market consists of sales of self-sterilizing hospital bed surfaces, antimicrobial surgical drapes, self-disinfecting medical device enclosures, antimicrobial medical packaging systems, and self-sterilizing examination gloves. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The self sterilizing medical devices market research report is one of a series of new reports that provides self sterilizing medical devices market statistics, including self sterilizing medical devices industry global market size, regional shares, competitors with a self sterilizing medical devices market share, detailed self sterilizing medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the self sterilizing medical devices industry. This self sterilizing medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.